535Accesses
7Citations
This is a preview of subscription content,log in via an institution to check access.
Access this article
Subscribe and save
- Starting from 10 chapters or articles per month
- Access and download chapters and articles from more than 300k books and 2,500 journals
- Cancel anytime
Buy Now
Price includes VAT (Japan)
Instant access to the full article PDF.
Explore related subjects
Discover the latest articles, books and news in related subjects, suggested using machine learning.References
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 2000.
Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 2005, 162:1133–1141.
Volkmar F, Cook E Jr, Pomeroy J, et al.: Summary of the practice parameters for the assessment and treatment of children, adolescents and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999, 38:1611–1616.
Lecavalier L: Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics and empirical classification. J Autism Dev Disord 2006, 36:1101–1114.
Myers SM, Johnson CP: Management of children with autism spectrum disorders. Pediatrics 2007, 120:1162–1182.
Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002, 347:314–321.
Shea S, Turgay A, Carrol A, et al.: Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004, 114:e634-e641.
Valecenti-McDermott MR, Demb H: Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. J Child Adolesc Psychopharmacol 2006, 16:549–560.
Stigler KA, Posey DJ, McDougle CJ: Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 2004, 14:455–463.
Owen R, Sikich L, Marcus RN, et al.: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorders. Pediatrics 2009, 124:1533–1540.
Author information
Authors and Affiliations
Department of Psychiatry, University of Pennsylvania School of Medicine/The Children’s Hospital of Philadelphia, The Behavioral Health Center, Suite 400, 3440 Market Street, Philadelphia, PA, 19104, USA
Tami D. Benton
- Tami D. Benton
Search author on:PubMed Google Scholar
Corresponding author
Correspondence toTami D. Benton.
Rights and permissions
About this article
Cite this article
Benton, T.D. Aripiprazole to Treat Irritability Associated With Autism: A Placebo-Controlled, Fixed-Dose Trial.Curr Psychiatry Rep13, 77–79 (2011). https://doi.org/10.1007/s11920-010-0172-0
Published:
Issue date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative